The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Karagiannis, T., Tsapas A., Athanasiadou E., Avgerinos I., Liakos A., Matthews D. R., et al. (2021).  GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Res Clin Pract. 174, 108737.
Karagiannis, A., Tziomalos K., Kakafika A. I., Athyros V. G., Harsoulis F., & Mikhailidis D. P. (2008).  Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.. Endocr Relat Cancer. 15(3), 693-700.
Karagiannis, A., Balaska K., Tziomalos K., Tokalaki-Nikolaidou L., Papayeoryiou A., & Zamboulis C. (2004).  Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke.. Eur Neurol. 51(3), 148-52.
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.. Core Evid. 12, 1-10.
Karagiannis, A., Tziomalos K., Kakafika A., Florentin M., & Athyros V. Gabriel (2007).  Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.. Nephrol Dial Transplant. 22(1), 293.
Karagiannis, A., Tziomalos K., Anagnostis P., Gossios T., & Athyros V. G. (2009).  Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?. Angiology. 60(4), 397-402.
Karagiannis, A., Tziomalos K., & Zamboulis C. (2004).  Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients.. Eur Heart J. 25(21), 1967.
Karagiannis, A., Tziomalos K., Mikhailidis D. P., Semertzidis P., Kountana E., Kakafika A. I., et al. (2010).  Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients.. Neurol Res. 32(3), 326-31.
Karagiannis, A., Diddi N., & Ward D. E. (2016).  On the Origin of Dolabriferol: Total Synthesis via Its Putative Contiguous Precursor.. Org Lett. 18(15), 3794-7.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications. Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
Karagiannis, T., Bekiari E., Manolopoulos K., Paletas K., & Tsapas A. (2010).  Gestational diabetes mellitus: why screen and how to diagnose.. Hippokratia. 14(3), 151-4.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., Kakafika A. I., Tziomalos K., Liberopoulos E. N., et al. (2007).  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opin Ther Targets. 11(2), 191-205.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., et al. (2007).  Serum uric acid as an independent predictor of early death after acute stroke.. Circ J. 71(7), 1120-7.
Karagiannis, A., & Harsoulis F. (2005).  Gonadal dysfunction in systemic diseases.. Eur J Endocrinol. 152(4), 501-13.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., & Harsoulis F. (2007).  Pheochromocytoma: an update on genetics and management.. Endocr Relat Cancer. 14(4), 935-56.
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy. Core Evidence. Volume 12, 1 - 10.
Karagiannis, A., Tziomalos K., Pagourelias E. D., Gossios T. D., & Athyros V. G. (2010).  Effect of antihypertensive drug-associated diabetes on cardiovascular risk.. Hellenic J Cardiol. 51(3), 195-9.
Karagiannis, T., Boura P., & Tsapas A. (2014).  Safety of dipeptidyl peptidase 4 inhibitors: a perspective review.. Ther Adv Drug Saf. 5(3), 138-46.
Karagiannis, T., Tsapas A., Bekiari E., Toulis K. A., & Nauck M. A. (2024).  A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.. Diabetes Care. 47(2), 184-192.
Karagiannis, A., Skolarikos A., Alexandrescu E., Basic D., Geavlete P., Maletta A., et al. (2017).  Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study.. Arch Ital Urol Androl. 89(3), 173-177.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.. Ther Adv Drug Saf. 7(2), 36-8.
Karagiannis, A., Tziomalos K., Kakafika A., Harsoulis F., & Zamboulis C. (2004).  Paralysis as first manifestation of primary aldosteronism.. Nephrol Dial Transplant. 19(9), 2418-9.
Karagiannis, T., Liakos A., Bekiari E., Athanasiadou E., Paschos P., Vasilakou D., et al. (2015).  Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.. Diabetes Obes Metab. 17(11), 1065-74.
Karagiozoglou-Lampoudi, T., Zellos A., Vlahavas G., Kafritsa Y., Roma E., Papadopoulou A., et al. (2013).  Screening for coeliac disease in preschool Greek children: the feasibility study of a community-based project.. Acta Paediatr. 102(7), 749-54.
Karagiozoglou-Lampoudi, T., Daskalou E., Vargiami E., & Zafeiriou D. (2012).  Identification of feeding risk factors for impaired nutrition status in paediatric patients with cerebral palsy.. Acta Paediatr. 101(6), 649-54.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.